Researchers at La Jolla Institute for Immunology (LJI) are designing better therapies for treating Ebola virus and its deadly relatives.
Mar 17, 2022
0
65
The Ebola virus can hide in the brains of monkeys that have recovered after medical treatment without causing symptoms and lead to recurrent infections, according to a study by a team I led that was published in the journal ...
Mar 16, 2022
0
22
In a groundbreaking study published today, scientists describe how Ebola virus, which can persist in certain areas of the body, can re-emerge to cause fatal disease—even long after treatment with monoclonal antibodies. ...
Feb 9, 2022
0
322
Coronavirus disease 2019 (COVID-19) has become a global pandemic. Currently, SARS-CoV-2 live virus-associated experiments need to be handled in biosafety level 3 (BSL-3) facilities. Previously, researchers had successfully ...
Dec 6, 2021
0
3
The University of Oxford have begun recruiting for a Phase I trial to test an Ebola vaccine in human volunteers—with the first vaccinations having already taken place.
Nov 11, 2021
0
4
The global death toll from COVID-19, which is set to pass five million, is already far worse than most other viral epidemics of the 20th and 21st centuries.
Nov 1, 2021
0
13
Most people are wondering when and how the COVID pandemic will end and there are still no easy answers.
Sep 20, 2021
0
70
Ebola survivors can relapse and trigger outbreaks at least five years after infection, and long-term follow-up of former patients is needed to prevent devastating flare-ups, according to new research.
Sep 15, 2021
0
199
Johnson & Johnson's two-dose Ebola vaccine regimen is safe, well tolerated and produces a strong immune response in people over the age of one, according to two new papers published in The Lancet Infectious Diseases.
Sep 14, 2021
0
10
There is "no evidence" that a Guinean woman who tested positive for Ebola after arriving in neighbouring Ivory Coast had the disease, the WHO said on Tuesday citing a new analysis from a lab in France.
Sep 1, 2021
0
5
